NXN

NXN (nucleoredoxin) is a redox-active protein that functions as a regulatory node controlling both EMT-associated transcription factors and WNT/β-catenin signaling in development and cancer (PMID:35927236). In hepatocellular carcinoma cells, NXN forms a ternary complex with the transcription factor Snail and the deubiquitylase DUB3, antagonizing DUB3-mediated deubiquitylation of Snail and thereby driving Snail toward ubiquitin-proteasome degradation; this Snail-suppressing activity underlies NXN's anti-proliferative and anti-metastatic effects, which are lost upon Snail depletion (PMID:35927236). NXN's own abundance is set by the RING E3 ligase KCMF1, which binds NXN and targets it for K63-linked ubiquitination; loss of NXN activates β-catenin signaling and promotes ovarian cancer cell proliferation, migration, and invasion (PMID:41721648). Consistent with a role upstream of WNT, Nxn-deficient mice show reduced canonical and non-canonical WNT signaling in the developing pituitary, delayed differentiation of pituitary stem cells into hormone-producing cells, and craniofacial defects including cleft palate. Beyond these contexts, the biochemical basis of NXN's redox activity has not been characterized in the available corpus.

1. 2022 Medium

   Established that NXN acts as a tumor suppressor by controlling the stability of the EMT driver Snail, answering how NXN restrains cancer cell proliferation and metastasis at the molecular level.

   Evidence Reciprocal Co-IP defining an NXN-Snail-DUB3 ternary complex, with Snail-depletion rescue and in vivo metastasis assays in hepatocellular carcinoma cells

   PMID:35927236

   Open questions at the time

   • Mechanism by which NXN inhibits DUB3 catalytic activity not resolved
   • Whether NXN redox activity is required for Snail/DUB3 regulation untested
   • Single lab; effect in other cancer types not assessed
2. 2026 Medium

   Identified how NXN protein levels are themselves regulated, showing KCMF1 targets NXN for K63-linked ubiquitination and that NXN loss derepresses β-catenin signaling in ovarian cancer.

   Evidence IP-LC/MS and label-free proteomics substrate identification, Co-IP validation, and KCMF1/NXN perturbation with functional and xenograft assays

   PMID:41721648

   Open questions at the time

   • K63-linked ubiquitination typically signals non-degradative fates; how it reduces NXN levels here is not mechanistically dissected
   • Direct link between NXN loss and β-catenin activation not biochemically mapped
   • Ubiquitination site(s) on NXN not defined
3. 2025 Medium

   Placed NXN upstream of WNT signaling in vivo, demonstrating it is required for pituitary stem cell differentiation and normal craniofacial development.

   Evidence Nxn knockout mouse with WNT reporter assays, single-cell RNA-seq differentiation trajectories, and histology of pituitary and craniofacial structures (preprint)

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • Molecular mechanism by which NXN modulates canonical vs non-canonical WNT not defined
   • Relationship between developmental WNT role and cancer β-catenin role unresolved

• The biochemical basis of NXN's redox (nucleoredoxin) activity and how it mechanistically connects its roles in Snail degradation, KCMF1 regulation, and WNT signaling remain unestablished.
• No structural or enzymatic characterization of NXN redox function in the corpus
• No unified model linking the three reported contexts
• Direct substrates or redox targets of NXN not identified